Clinical Trial Update: Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluated platelet-rich plasma treatment for medial retinaculum tear after medial patellar dislocation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medial Retinaculum Tear
• Patellar Dislocation

Drugs mentioned

• Platelet-rich plasma therapy (platelet-rich plasma)

Snippet

Sponsor: Meir Medical Center | Conditions: Patella-Dislocation | Phase 2, Phase 3 | Status: COMPLETED